Hydrazide-containing CFTR inhibitor compounds and uses thereof
The invention provides compositions, pharmaceutical preparations and methods for inhibition of cystic fibrosis transmembrane conductance regulator protein (CFTR) that are useful for the study and treatment of CFTR-mediated diseases and conditions. The com
-
Page/Page column 27
(2008/06/13)
More Articles about upstream products of 6248-33-5